A phase I study of daily afatinib, an irreversible ErbB family blocker, in combination with weekly paclitaxel in patients with advanced solid tumours
Titel:
A phase I study of daily afatinib, an irreversible ErbB family blocker, in combination with weekly paclitaxel in patients with advanced solid tumours
Auteur:
Suder, A. Ang, J.E. Kyle, F. Harris, D. Rudman, S. Kristeleit, R. Solca, F. Uttenreuther-Fischer, M. Pemberton, K. Pelling, K. Schnell, D. de Bono, J. Spicer, J.